Loomis-Price L - Search Results

1

Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG.

Lowell GH, Kaminski RW, VanCott TC, Slike B, Kersey K, Zawoznik E, Loomis-Price L, Smith G, Redfield RR, Amselem S, Birx DL. Lowell GH, et al. J Infect Dis. 1997 Feb;175(2):292-301. doi: 10.1093/infdis/175.2.292. J Infect Dis. 1997. PMID: 9203649

2

Delayed-type hypersensitivity skin testing using third variable loop peptides identifies T lymphocyte epitopes in human immunodeficiency virus-infected persons.

Sitz KV, Loomis-Price LD, Ratto-Kim S, Kenner JR, Sau P, Eckels KH, Redfield RR, Birx DL. Sitz KV, et al. J Infect Dis. 1997 Oct;176(4):1085-9. doi: 10.1086/516517. J Infect Dis. 1997. PMID: 9333173

3

Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection.

Loomis-Price LD, Cox JH, Mascola JR, VanCott TC, Michael NL, Fouts TR, Redfield RR, Robb ML, Wahren B, Sheppard HW, Birx DL. Loomis-Price LD, et al. J Infect Dis. 1998 Nov;178(5):1306-16. doi: 10.1086/314436. J Infect Dis. 1998. PMID: 9780250

4

Efficacy testing of recombinant human immunodeficiency virus (HIV) gp160 as a therapeutic vaccine in early-stage HIV-1-infected volunteers. rgp160 Phase II Vaccine Investigators.

Birx DL, Loomis-Price LD, Aronson N, Brundage J, Davis C, Deyton L, Garner R, Gordin F, Henry D, Holloway W, Kerkering T, Luskin-Hawk R, McNeil J, Michael N, Foster Pierce P, Poretz D, Ratto-Kim S, Renzullo P, Ruiz N, Sitz K, Smith G, Tacket C, Thompson M, Tramont E, Yangco B, Yarrish R, Redfield RR. Birx DL, et al. Among authors: loomis price ld. J Infect Dis. 2000 Mar;181(3):881-9. doi: 10.1086/315308. J Infect Dis. 2000. PMID: 10720508 Clinical Trial.

5

V3 seroreactivity and sequence variation: tracking the emergence of V3 genotypic variation in HIV-1-infected patients.

Michael NL, Davis KE, Loomis-Price LD, VanCott TC, Burke DS, Redfield RR, Birx DL. Michael NL, et al. AIDS. 1996 Feb;10(2):121-9. doi: 10.1097/00002030-199602000-00001. AIDS. 1996. PMID: 8838699 Clinical Trial.

6

Cross-subtype neutralizing antibodies induced in baboons by a subtype E gp120 immunogen based on an R5 primary human immunodeficiency virus type 1 envelope.

VanCott TC, Mascola JR, Loomis-Price LD, Sinangil F, Zitomersky N, McNeil J, Robb ML, Birx DL, Barnett S. VanCott TC, et al. J Virol. 1999 Jun;73(6):4640-50. doi: 10.1128/JVI.73.6.4640-4650.1999. J Virol. 1999. PMID: 10233923 Free PMC article.

7

Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection.

Kim JH, Mascola JR, Ratto-Kim S, VanCott TC, Loomis-Price L, Cox JH, Michael NL, Jagodzinski L, Hawkes C, Mayers D, Gilliam BL, Birx DC, Robb ML. Kim JH, et al. Among authors: loomis price l. AIDS Res Hum Retroviruses. 2001 Jul 20;17(11):1021-34. doi: 10.1089/088922201300343708. AIDS Res Hum Retroviruses. 2001. PMID: 11485619

8

Linear epitope mapping of humoral responses induced by vaccination with recombinant HIV-1 envelope protein gp160.

Loomis-Price LD, Levi M, Burnett PR, van Hamont JE, Shafer RA, Wahren B, Birx DL. Loomis-Price LD, et al. J Ind Microbiol Biotechnol. 1997 Jul;19(1):58-65. doi: 10.1038/sj.jim.2900410. J Ind Microbiol Biotechnol. 1997. PMID: 9281853

9

HIV type 1 subtype E-infected patients with broadened, dual (B/E) V3 loop serology have increased cross-neutralizing antibodies.

Polonis VR, De Souza MS, Chanbancherd P, Chantakulkij S, Jugsudee A, Loomis-Price LD, Vancott TC, Garner R, Markowitz LE, Brown AE, Birx DL. Polonis VR, et al. Among authors: loomis price ld. AIDS Res Hum Retroviruses. 2001 Jan 1;17(1):69-79. doi: 10.1089/088922201750056807. AIDS Res Hum Retroviruses. 2001. PMID: 11177385

10

Comparison between env-specific T-cell epitopic responses in HIV-1-uninfected adults immunized with combination of ALVAC-HIV(vCP205) plus or minus rgp160MN/LAI-2 and HIV-1-infected adults.

Ratto-Kim S, Loomis-Price LD, Aronson N, Grimes J, Hill C, Williams C, El Habib R, Birx DL, Kim JH. Ratto-Kim S, et al. Among authors: loomis price ld. J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):9-17. doi: 10.1097/00126334-200301010-00003. J Acquir Immune Defic Syndr. 2003. PMID: 12514409 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters